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ABSTRACT
Bacteria resistant to most or all available antibiotics are causing increasingly
serious problems and raising widespread fears of returning to a pre-antibiotic era of
untreatable infections and epidemics. Despite intensive work by drug companies, no new
classes of antibiotics have been found in the last 30 years . There are hopes that the
newfound ability to sequence entire microbial genomes and to determine the molecular
bases of pathogenicity will open new avenues for treating infectious disease, but other
approaches are also being sought with increasing fervor. One result is a renewed interest
in the possibilities of bacteriophage (phage) therapy - the harnessing of a specific kind of
viruses that attack only bacteria to kill pathogenic microorganisms.
Bacteriophages are bacterial viruses. They are viruses that infect specific bacteria
and destroy them. A bacteriophage virus infects a host bacterial cell by attaching itself to
the surface of a bacterial cell and then injecting its viral nucleic acid into the cell.
Hundreds of new bacteriophage virus particles are then formed within the bacterial cell as
the virus replicates itself. The bacterial cell is then destroyed, releasing the new
bacteriophage viruses to infect other bacterial cells. The process is repeated within the
bacterial cell population about every 20 minutes until the bacteria are eliminated.
This paper is written primarily to put phage therapy in a historical and ecological
context; to explore the roles of bacteriophages in maintaining microbial ecology; and in
helping to deal with the growing crisis in antibiotic resistant microbes.
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CHAPTER I
fNTRODUCTION
There is a crisis facing modem medicine . The advanced care on offer in our
hospitals, the transplants, cancer therap y and intensive treatments of all kinds, are under
threat from bacterial infections that cannot be treated with antibiotics . in the 1920s,
surgery was held back by the inability to fight the bacteria that infected surgical wounds
rather than by any lack of technique . Antibiotics made infection control possible and so
hospital surgery developed into the sophisticated service we take for granted today. Many
sophisticated treatments, like chemotherapy for cancer patients and drugs used by
transplant patients so that they don 't reject their new organs, depend on the suppression
of the immune system . The terrible rise of bacteria resistant to our best antibiotics
threatens these procedures . Without an alternative to antibiotics, medicine risks findin g
itself back in the pre-antibiotic era . One possible alternative to antibiotics, in many
medical situations, may come from a re-examination of approach to infection control last
used in the West in the thirties, but used regularly in the Republic of Georgia and across
the former Soviet Union. It is an approach that was pushed aside by the miracle of
antibiotics. It is the use of viruses to kill bacteria
History of Antibiotics and Antibiotic Chemotherapy
The first antibiotic, penicillin, was discovered in 1929 by Sir Alexander Flem ing
The period of the late 1940s and early 1950s saw the discovery and introducti on of
streptomycin, chloramphenicol , and tetracycline, and the age of antibiotic chemotherap y
came into full bein g These antibiotics were effective against the full array of bacterial
pathogens including Gram-p ositive and Gram-negative bacteria, intracellular parasites ,
and the tuberculosi s bacillus . However , by 1953, during a Shigella outbreak in Jap an, a
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strain of the dysentery bacillus was isolated which was multiple drug resistant, exhibiting
resistance to chloramphenicol , tetracycline, streptomycin, and the sulfanilamides. There
was also evidence mounting that bacteria could pass genes for multiple drug resistance
between strains and even between species. It was also apparent that Mycobacterium

tuberculosis was capable of rapid development of resistance

to

streptomycin which had

become a mainstay in tuberculosis therapy.

Bacterial Resistance to Antibiotics
Antibiotics work by either killing bacteria or by inhibitin g growth. Each time we
take antibiotics, sensitive bacteria are killed, but resistant ones may be left to grow and
multiply.
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Figure 1: Antibiotic-resistant bacteria

Antibiotic-re si stant bacteria owe their drug insen sitivity to resistance genes . For example .
as see n in Fig . I, such genes might code for "effl ux" pumps that eje c t antibio tics from
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cells (a). Or the genes might give rise to enzymes that inactivate the antibiotics (b) or
change the internal binding site of the antibiotic (c ). Obviously, if a bacterial pathogen is
able to develop or acquire resistance to an antibiotic, then that substance becomes useless
in the treatment of infectious disease caused by that pathogen (unless the resistance can
somehow be overcome with secondary measures). So as pathogens develop resistance,
we must find new (different) antibiotics to fill the place of the old ones in treatment
regimes. However, most infections still respond to first-line antibiotics like ampicillin.
And of those that don't, most can still be wiped out with more powerful medications. The
trouble is that using stronger drugs encourages bacteria to become resistant to those
drugs. To keep pace with evolving bacteria, science has stepped up development of new
antibiotics. But health officials warn that if we want to count on our future ability to
conquer infection, we ought to become more antibiotic-conservative now.

The Medical Problem of Bacterial Drug Resistance
Not only is there a problem in finding new antibiotics to fight old diseases
(because resistant strains of bacteria have emerged), but there is a parallel problem to find
new antibiotics to fight new diseases. In the past two decades, many "new" bacterial
diseases have been discovered (Legionnaire's disease, gastric ulcers, Lyme disease , toxic
shock syndrome, "skin-eating" streptococci) . We are only now able to examine patterns
of susceptibility and resistance to antibiotics among new pathogens that cause these
diseases. Broad patterns of resistance exist in these pathogens, and it seems likely that we
will soon need new antibiotics to replace the handful that are effecti ve now agai nst these
bacteria, especially as resistance begins to emerge among them in the selective
environment antibiotic chemotherapy.
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Considering an Alternative Therapy
Bacteriophage therapeutic products have been used successfully in other countries
for decades for the treatment of various infections. The advent of antibiotics virtually
stopped bacteriophage research in North America. However bacteriophage were and are
used successfully in many countries. More recently, bacteriophage research has played a
key role in the development of modem biotechnology and molecular genetics . Phage
Therapeutics International Inc. (PhageTx), a new and rising company is using the
knowledge gained over past decades to provide solutions to the emerging threat of
antibiotic-resistant infections. The resulting pharmaceutical preparations are anticipated
to be used in the US and throughout the world.

Statement of Purpose
Currently, bacteria are growing more resistant and are mutating in such a fast rate
that they are immune to attack by antibiotics. Therefore, new methods are currently being
developed as potential alternatives to using antibodies. Phage therapy is one of the
promising on-going research initiatives to replace or complement the use of antibiotics on
a large scale for mass production. Hence, the purpose of this research paper is to
examine phage therapy in the following categories :
•

Historical and biomedical context.

•

Roles of phages in maintaining microbial ecology.

•

Research related to phage biology and its practical applications.

Significance of Study
Every time we take an antibiotic, the weakest bacteria are killed and the strong
ones, resi stant to the antibiotic are left to multiply . The selection process is fairly
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straightforward. When an antibiotic attacks a group of bacteria, cells that are highly
susceptible to the medicine will die . But cells that have some resistance from the start, or
that acquire it later (through mutation or gene exchange), may survive, especially if too
little drug is given to overwhelm the cells that are present. Those cells, facing reduced
competition from susceptible bacteria, will then go on to proliferate. When confronted
with an antibiotic, the most resistant cells in a group will inevitably out compete all
others. The key problem with antibiotics is that they are unchanging chemicals. Once
bacteria develop resistance to them , they become redundant. But phage is different. The
beauty of phage as a medicine is that they are alive, so they can change, just as bacteria
do . Phage technology gives an indication into how the bacteria, which may be resistant to
antibiotics, may nevertheless be destroyed . When bacteria evolve, phage evolves
alongside. Phage offers the world a naturally evolving medicine, able to fight off any new
bacteria that emerge

Research Questions
This research paper will address the following research questions
I. What are phages ?
2. How do phages destroy bacteria ?
3

How effective are phages as an alternative to antibiotics?

4

What are the disadvantages of phage medical technology and how can phage
technology be improved to make it a more effective health policy tool for mass
production?

5

What is the future potential for phage biology as a medical technology in the 21 Sl
century ?

6

Organization of Study
The introductory chapter, Chapter 1, provides background information, state ment
of the problem, significance of the study and research questions pertaining to the study .
The remainder of this paper is divided into the following sections. Chapter IT consists of a
review of existing literature. Chapter III deals with the analysis and major findings of the
study and addresses research questions I & 2. Chapter IV consists of discussing these
findings and answering research questions 3 & 4 . Chapter V draws conclusions about the
study, addresses research question 5 and offers some reconunendations .

CHAPTER n
REVIEW OF LITERATURE

Discovery
Before penicillin became the medical world's darling, crusading doctors
crisscrossed the globe armed with bacteria-killing viruses that, when administered to
diseased patients via infection or potion, could be powerful healers. First discovered in
France's Pasteur institute in 1917, phages are considered medicine's most promising
panacea for an array of nasty diseases until antibiotics debuted in the 1940s, Drugs such
as penicillin seemed infallible, while phages, their biology poorly understood, were hits
or misses, The once celebrated viruses slipped into oblivion.
Background
A century ago , Hankin (1896) reported that the waters of the Ganges and Jumna
rivers in India had marked antibacterial action which could pass through a very fine
porcelain filter but whose activity was destroyed by boiling. He particularly studied the
effects on Vibrio cholerae and suggested that the substance responsible was what kept
cholera epidemics from being spread by ingestion of the water of these rivers. However,
he did not further explore the phenomenon
It was English investigator Edward Twort (1915) and French bacteriologist Felix
d'Herelle ( 1917) who thorou ghly investigated the remarkable and interesting
phenomenon They discovered that bacteria may suffer a "filterable virus disease,"
D'H erelle went on to condu ct a series of basic experiments. He emulsifi ed a bit of feces
from a case of dysentery in broth , then passed the emulsion through a bacterial filter. He
found that the clear filtrate (free of any visible microbes) contained an agent of some kind
which would destro y dysente ry germs If a trace of this filtrate were added to a young
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broth culture of dysentery bacilli, all or nearly all of the organisms were dissolved (lysed)
and the previously cloudy culture became clear in a few hours And if a trace of this
culture was placed in another young broth culture of dysentery organisms, the same thing
occurred, and by successive transfers the mysterious bacteria-dissolving agent could be
carried along indefinitely When a drop of filterable entities came in contact with a
young growth of dysentery germs on a solid medium, such as an agar slant or plate, the
filterable entities were capable of destroying the bacterial cultures to produce plaques
(small cleared areas on bacterial lawns where lysis has taken place) It was d'Herelle,
working at the Pasteur Institute in Paris, who gave them the name "bacterio phage",
commonly abbreviated to phage This term was derived from the Greek word, phagein,
meaning "to eat"

Felix d'Herelle
D 'HereIle went on to carefully characterize bacteriophages as viruses which
multiply in bacteria and worked out the details of infection by various phages of different
bacterial hosts under a variety of environmental conditions, always working to combine
natural phenomena with laboratory findings, to better understand immunity and natural
healing

from infectious disease. D 'HereIle summarized the early phage work in a 300

page book "The Bacteriophage". He wrote classic descriptions of plaque formation and
composition, infective centers, the lysis process, host specificity of absorption and
multiplication, the dependence of phage production on the precise state of the host,
isolation of phages from sources of infectious bacteria and the factors controlling stability
of the free phage He quickly became fascinated with the apparent role of phages in the
natural control of microbial infections He noted for example the frequent specificities of
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the phages isolated from recuperating patients for their own disease organisms and the
rather rapid variations over time in their phage populations. He thus worked throughout
his life to develop the potential of using properly selected phages as therapeutic agents
against the most devastating health problems of the day . However, he initially focussed
on simply understanding phage biology Thus, the first known report of successful phage
therapy came not from d' Herelle but from Bruynoghe and Maisin (1921), who used
phage to treat staphylococcal skin infections
In 1925, d'Herelle became a health officer for the League of Nations, based in
Alexandria, Egypt, with special responsibility for controlling infectious disease on ships
passing through the Suez Canal. Phage therapy and sanitation measures were the primary
tools in his arsenal to deal with major outbreaks of infectious disease ranging from simple
infections to the bubonic plague throughout the Middle East and India Pharmaceutical
titian Eli Lilly listed phage liquids in its product catalog in the 1930s, and Sinclair
Lewis's Pulitzer Prize-winning 1925 novel "Arrowsmith" featured ad' Herelle-like
doctor who used phages. D'Herelle returned permanently to Europe in 1933, spending
much time the following two years in Tbilisi, Georgia, helping to set up an international
Bacteriophage Institute there

Bacteriophage Institute, Tbilisi
The most extensive and least widely known work on phage therapy was carried
out under the auspices of the Bacteriophage Institute at Tbilisi, d'Herelle's institute in the
former Soviet republic of Georgia (Summers, 1993). Phage therapy is part of the general
standard of care there, used especially extensively in pediatric, bum and surgical hospital
settings Phage preparation was carried out on an industrial scale, employing over I, 200
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people Tons of tablets, liquid preparation and spray containers of carefully-selected
mixtures of phages for therapy and prophylaxis were shipped throughout the neighboring
states each day . They generally were available both over the counter and through
physicians The largest use was in hospitals, to treat both primary and nosocomial
(hospital-acquired) infections, alone or in conjunction with chemical antibiotics : They
played a particularly important role when antibiotic-resistant organisms were found. The
military is still one of the strongest supporters of phage therapy research and
development, because phages have proven so useful for wound and burn infections as
well as for preventing debilitating gastrointestinal epidemics among the troops
In 1938, the Bacteriophage Institute was merged with the Institute of
Microbiology & Epidemiology, under direction of the People's Commissary of Health of
.' ~

Georgia and took on the leadership role in providing bacteriophages for therapy and

."
:~
.~

bacterial typing throughout eastern Europe. Under orders from the Ministry of Health,

:"

'.
hundreds of thousands of samples of pathogenic bacteria were sent to the Institute to
isolate more effective phage strains and better characterize their usefulness . The institute
hou sed an electron microscope facility, a permanent strain collection, and laboratories
studying phages of the enterobacteria, staphylococci and pseudomonads. Groups
involved with ongoing research formulated new phage cocktails, undertook vaccine
production, and conducted immunology studies among other therapeutic approaches .
Indeed, the institute held impressive success rates; according to one 1985 study, for
example, the institute's phages were 80 percent effe ctive against enterococcus, whi ch can
spur fatal heart-valve infections . (Ackermann, 1996)
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Ever since the dissolution of the So viet Union , Georgia has had very little money
available for science, but some research continues, despite virtually no funding for
salaries or supplies The industrial plant was privatized a few years ago and put to other
uses, so the phages currently used for therapy must be grown in large carboys, the
appropriate mixtures made , and then transferred to vials and sealed by hand However,
the checks for sterility and efficacy on the designated bacteria are still just as careful.
Unfortunately, until important equipment such as the electron microscope is repaired or
replaced and electricity made more predictable, phage preparations can no longer be
checked to be sure that the phage present are of the appropriate mixtures of morphotypes,
physical shape or size . The institute's scientists still continue to do the best they can
under the circumstance, and many in Tbilisi feel they sincerely owe their lives to the
group's efforts . Extensive therapeutic work still goes on in local surgical, bum, pediatric
and infectious disease hospitals, and in local clinics for ambulatory patients, including
one on the grounds of the Institute.

Specific problems of Early Phage Therapy Work
Though modern know-how may help scientists avoid the technical problems
d 'Herelle may have had, most of them still are not read y to declare phages the ultimate
remedy . "T here has been too much hyperbole and far too few well-controlled
experiments," says Ian Molineux, a phage biology researcher at the University of Texas
Austin . Jim Bull , an evolutionary geneticist also at the University of Texas-Austin, has
worked with Bruce Levin, a biology professor at Emory University, to treat mice infected
with fatal do ses of F. coli. In one experiment, infected mice treated with phages had a 92
percent survi val rate, compared with 33 percent for those receiving the antibiotic

12

streptomycin Still, Bull doesn 't mind calling himself skeptical " It sounds simple to let a
phage attack something," he says, " but the complexities of infection inside our bodies
may get in the way of making that as easy as we'd like to think ." For instance, bacteria
can " hide out" inside cells where phages can 't reach
However, it appears that phage therapy simply was never given a sufficient and
appropriate trial, and reassessment is warranted (Eaton and Bayne-Jones, 1931). It is thus
important to consider in some detail potential reasons for the earl y problems and the
questions as to efficacy. These included :
I. Paucity of understanding of the heterogeneity and ecology of both the phages and the
bacteria involved .
2

Failure to select phages of high virulence against the target bacteria before using them
in patients

3. The use of single phages in infections which involved mixtures of different bacteria .
4 . Emergence of resistant bacterial strains. T his can occur by selection of resistant
mutants (a frequent occurrence if only one phage strain is used against a particular
bacterium) .
5. Failure to neutralize gastric pH prior to oral phage administration.
6. Failure to appropriately characterize or titer phage preparations, some of which were
totally inactive
7. Inactivation of phages by both specifi c and nonspecific factors in bod y fluids.
8

Liberation of en do toxins as a consequence of widespread lysis of bacteria within the
body (whi ch physicians call the Herxheirner reaction ) This can lead to toxic shock,
and is a potential problem with chemical antibiotics as well.

;1'

'.
"' ..

L1

9. Lack of availability or reliability of bacterial laboratories for carefully identifying the
pathogens involved, necessitated by the relative specificity of phage therapy
In making the choice to again explore the possibilities of phage therapy many of their
potential advantages need to be considered. However, these will be discussed in Chapter

IV.

.'....
,
"

CHAPTER III
MODE OF STUDY
A comparative analysis of existing literature qualitatively analyzing the utility of
phage therapy as an alternati ve to antibiotics. Based on this theoretical model of
qualitative analysis, the study will demonstrate the effectiveness of phage therapy.

Viruses
Viruses from the Latin virus, meaning "poison", straddle the definition of life.
They lie somewhere between supra molecular complexes and very simple biological
entities. Viruses contain some of the structures and exhibit some of the activities that are
missing many of the others . In general, viruses are entirely composed of a single strand of
genetic information encased within a protein capsule. Viruses lack most of the internal
structure and machinery, which characterize 'life', including the biosynthetic machinery
that is necessary for reproduction. In order for a virus to replicate it must infect a suitable
host cell. The detailed structure of a virus can be seen in Fig. 2.

~ ' ~ . .: -..Jk'1 _._

_ .- '. t\ UG1e;l: aClu

.. ." .··· C Olh r

hil
pin:;

Figure 2: Detailed structure or complex viruses
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Today, host cells are often maintained in tissue (cell) culture by simply placing a
few cells in a glass or plastic container with appropriate medium. The cells can then be
infected with the animal virus to be studied. Viruses infect all sorts of cells, from
bacterial cells to human cells, however, they are all very specific. Bacteriophages infect
only bacteria, the tobacco mosaic virus infects only plants , and the rabies virus infects
only mammals, for example. We know that human viruses even specialize in a particular
tissue. Human immunodeficiency virus (HIV) specifically infects human T lymphocytes
which carry a particular surface protein called CD4, the polio virus reproduces only in
spinal nerve cells, and the hepatitis virus infects only liver cells. It is now believed that
viruses are derived from the very cell they infect and that the nucleic acids of viruses
come from their host cell genomes. Therefore, viruses must have evolved after cells came
into existence, and new viruses are probably evolving even now.

n_ <

Figure 3: Virus embedded in the bacterial cell wall

Viruses gain entry into and are specific to a particular host cell because portions
of the capsid (or the spikes of the envelope) adhere in a lock-and-key manner with a
receptor on the host cell plasma membrane (Bayer, 1968). Fig. 3 shows how such
penetration occurs . Their nucleic acid then take s up residence inside the cell. Once
inside, the nucleic acid codes for the protein units in the capsid.
In addition, the virus may have genes for a few special enzymes needed for the
virus to reproduce and exit the host's enzymes, ribosomes, transfer RNA (tRNA), and
ATP (adenosine triphosphate) for its own reproduction. In other words, a viru s takes over
the metabolic machinery of the host cell when it reproduces.

Bacteriophage T4 Virus
As established, a bacteriophage is a virus which infects bacteria.

Figure 4: Electron micrograph or the T4 bacteriophage
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In particular, the bacteriophage T4 (Fig. 4), belonging to the class of T-even
bacteriophages (Adams, 1959), is a virus which infects E. coli, a bacteria that has been
used extensively for molecular biology research.
The bacteriophage T4 exemplifies the life cycle of viruses . It exists as an inactive
virion until one of its extended 'legs' comes into contact with the surface of an E. coli
cell. Sensors on the ends of its 'legs' recognize binding sites on the surface of the host 's
celJ, and this triggers the bacteriophage into action (Fig. 5).

Figure 5: Bacteriophage entering a bacterial cell

Like a miniscule syringe, the sheath constricts, pushing the inner tube through the host 's
cell wall and membrane, forming a passageway for its nucleic acid (genetic blueprint)
into the interior of the cell. This genetic information subverts the host cell's normal
operation and sets the cell's biosynthetic machinery to work creating replicas of the virus .
These newly created viruses escape form the cell and then float about dormant until one
happens to come into contact with a new host cell. The spent virus shell (or

ho st) has fulfilled its principal functions; protection, adsorption, and injection of DNA ,
and will remain attached outside to the cell wall fragment even after the cell has lysed .

The Nature of Bacteriophages
There are two types of bacteriophage life cycles, termed the lytic cycle and the
lysogenic (prophage) cycle as shown in Fig . 6. In the lytic cycle , viral replication occurs
and the host cell undergoes lysi s , a breaking open of the cell to release viral particles. In
the lysogenic cycle, viral replication does not immediately occur, but replication may
take place time in the future. The bacteriophage, termed lambda, is capable of carrying
out either cycle.
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Lytic Cycle
The lytic cycle may be div ided into five stages: attachment, penetration,
biosynthesis, maturation, and release . As mentioned earlier, during attachment, portions
of the capsid combine with a receptor on the rigid bacterial cell wall in a lock-and-key
manner. During penetration, a vir al enzyme digests away part of the cell wall, and viral
DNA is injected into the bacterial cell. Bio synthesis of viral components begins after the
virus brings about inactivation of host genes not necessary to viral replication. The viru s
takes over the machinery of the cell in order to carry out viral DNA replication and
production of multiple copies of the capsid protein sub-units. During maturation , viral
DNA and capsids are assembled to produce several hundred viral particles. An average
sized E. coli cell can contain up to 200 new phage unit s at the end of this period .
Ly sozyme, an enzyme coded for by a viral gene, is produced (Watson, 1965 ). Th is
disrupts the cell wall , rele ases the phage particles and the bacterial cell dies as a result.
Upon release, the virulent phages can spread to other susceptible bacterial cells and begin
a new cycle of infe ction.

Lysogenic (Prophage) Cycle
With the lysogenic cycle the infected bacterium does not immedi ately produce
phage but may do so sometime in the future . In the meantime the phage is latent (not
acti vely replicating) . Following att achment and penetration, viral DNA beco mes
integrated into bacterial DNA with no destruction of host DNA . While latent , the vir al
DNA is called a prophage. The prophage is replicated along with the host DNA, a nd all
subseq uent cells, called lysogenic cells, c arr y a co py of the prophage. Certain

environmental factors, such as ultraviolet radiation , can induce the prophage to enter the
lytic stage of biosynthesis, followed by maturation and release.

Rational Phage Therapy
The effect of a phage upon susceptible bacteria is to bring about their dissolution
(lysis) during the stage of active growth in culture media. Such an effect can be seen in
Fig. 7.

Figure 7: A weakened bacterial cell, crowded with phages, has ruptured and released new viruses

The lytic action may be demonstrated in several simple ways with young cultures
of the organism in either broth or agar media. By making a series of dilutions of the
phage-containing filtrate and testing the activity of the se dilutions under standard
conditions the highest dilution capable of bringing about lysis in a certain time may be
determined, and thus the strength or potency of the phage may be measured.

Lytic Phages
A much better understanding of the interactions between lytic phage and bacteria
came from detailed one-step growth curve experiments expanding on the work of
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d ' Herelle (Doermann, 1952) These demonstrated an eclipse period during which the
DNA began replicating and there were no free phage in the cell, a period of accumulation
of intracellular phage, and lysis process which rele ased the phage to go in search of new
hosts (Strent, 1963) . The experimental guide undertook by d 'Herelle and others in
observing phage infection cycles are outlined next.

Lysis in Broth Cultures
Tubes of broth were heavily inoculated with a susceptible strain of bacteria, so
that a faint but distinct cloudiness was evident, then a few drops of the diluted phage
containing filtrate were added Another tube was similarly inoculated with the same
organism but the bacteriophage was not added . The latter served as the control. The tubes
were placed in the incubator, and examined at half-hour intervals during the following 5
to 6 hours. All tubes became more turbid as the growth of the bacteria proceeded and the
cloudiness continued to increase in the control tube, but in other tubes at about the fourth
hour on incubation there was a rather sudden change in the appearance of the culture The
previously turbid broth became clear or nearly clear within the space of a few minutes'
time , indicating that lysis of the bacteria had occurred . However, further incubation of the
cleared tubes usually resulted in the reappearance of cloudiness. This was du e to
multiplication of the few bacterial cells in the culture which were resistant to this
particular phage .

Action upon Agar Plate Cultures; Plaques
An agar plate was streaked in the usual manner with the bacteria and then with a
loopful of the bacteriophage After incubation, the resultin g ag ar plate culture showed an
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almost continuous mass of bacterial growth throughout the medium, but in the midst of
this growth, there appeared clear, round areas where the bacteriophage had acted upon
the organisms. These were termed plaques . An example of plaques in a lawn of bacteria
can be seen in Fig. 8.

Figure 8: Plaques appear as clear areas of lysis in a lawn of bacteria growing on the agar surface

An estimate of the potency of the bacteriophage in a particular filtrate was made
by setting up a series of such plates with serial dilutions of the filtrate, and counting the
plaques. Assuming that each plaque represented a single particle of phage it was only
necessary to count the plaques in each plate, multiply by the dilution of the filtrate used
in that plate and average the results. Thus a figure was obtained that indicated the number
the phage particles in the filtrate, or in other words, the concentration of bacteriophage
present.
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Plaques are important for several other reasons. They can be used as a tool in
taxonomy during the process of phage typing It is thought that distinct "races" of phages
exist, and that these may be distinguished by the size and character of the plaques they
produce in agar cultures and by other characteristics. Its most successful application has
been in the typing of coagulase-positive staphylococci and has permitted scientists to
trace the sources of staphylococcal epidemics
Motion picture studies of bacterial cultures under the influence of phage have
shown that the bacteria at first grow and multiply with unusual rapidity and all their vital
activities appear to be greatly exaggerated . Later, in the case of most species, the
bacterial cells absorb water and become greatly swollen. Then, when the concentration of
phage has reached a certain level, the cells burst and are destroyed (Bradley, 1965) Just
how a bacteriophage acts to start this destructive process is unknown The true
explanation of this remarkable phenomenon and an understanding of the real nature of
the bacteriophages must await the results of future research.

CHAPTER IV
DISCUSSION
Properties of Pbages

Naturally, the discovery of filterable, invisible, bacteria-destroying agents aroused
great interest the world over, and many investigators began to study the subject It was
real ized that the bacteriophage phenomenon was not only important in itself but was
especially worth analysis because of the obvious similarity of phages to the known
pathogenic filterable viruses. The intensive studies of phages which continue. have
greatly influenced modem ideas about viruses in general
The principal facts which have been established concerning bacteriophages and their
action are summarized below.
1. They are both self-replicating and self-limiting, since they will multiply only as long
as sensitive bacteria are present and then are gradually eliminated from the individual
and the environment.
2

They can be targeted far more specifically than can most antibiotics to the specific
problem bacteria, causing much less damage to the normal microbial balance in the
body The bacterial imbalance or "dysbiosis" caused by treatment with many
antibiotics can lead to serious secondary Infections involving relatively resistant
bacteria, often extending hospitalization time, expense and mortality Particular
resultant problems Include infection by pseudornonads, which are especially difficult
to treat, and the Clostridium difficilc, cause of serious diarrhea and membranous
colitis (Fekety, 1995)

..
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3. Phages can often be targeted to receptors on the bacterial surface which are involved
in pathogenesis, so that any resistant mutants are attenuated in virulence.
4. Few side effects have been reported for phage therapy .
5. Phage therapy would be particularly useful for people with allergies to antibiotics.
6. Appropriately selected phages can easily be used prophylactically to help prevent
bacterial disease in people or animals at times of exposure, or to sanitize hospitals and
help protect against hospital-acquired (nosocomial) infections .
7. Especially for external applications, phages can be prepared fairly inexpensively and
locally, facilitating their potential applications to under-served populations.
8. Phage can be used either independently or in conjunction with other antibiotics to
help reduce the development of bacterial resistance.

Recent Work Related to Phage Therapy
Levin and Bull (1996) and Barrow and Soothill (1997) have provided good
reviews of much of the work applying phage therapy in animals which has been carried
out in Britain and the United States ever since interest in the possibilities of phage
therapy began to resurface there in the early 80 's. The results in general are in very good
agreement with the clinical work described above in terms of efficacy, safety and
importance of appropriate attention to biology of the host-phage interactions, reinforcing
trust in the reported extensive eastern European results.
In Britain, H. W . Smith and M. B. Huggins (1982, 1983 ) carried out a series of
studies on use of phages on systemic E. coli infections in mice and then in diarrheal
disease in young calves. For example, they found that injecting a million colony-formin g

..
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units of a part icul ar pathogen ic strain intramuscul arly killed ten out o f te n of the mice,
but none died if they simultaneously infected ten thou sand pl aque-forming units of a
phage selected against the Kl capsule antigen of that bacterial strain. This phage
treatment was more effective than using such antibiotic s as tetracycline, streptomycin,
ampicillin or trimethoprim/sulfafurazole. Furthermore, the resi stant bacteria that emerged
had lost their capsule and were far less virulent. In calves, they found very high levels of
protection even though they did not succeed in isolating phages specific for the K88 or

K99 adhesive fimbriae, which play key roles in attachment within the sma ll intestine.
Still, the phage s were able to reduce the number of bacteria bound there by many orders
of magnitude and to virtually sto p the fluid loss. The results were particul arly effective if
"

the phage were present before or at the time of bacterial pre sentation , and if multiple

"

I,
I

ph ages with different attachment specificities were used. Furthermore, the phage could be
tran sferred from animal to animal, supporting the possibility of prophylacti c use in a
herd . If ph age were given only after the development of diarrhea , the severity of the
infection was still substantially reduced and none of the animal s died (S mith et al, 1987).
Levin and Bull (1996) carried out a detailed analysis of the populati on dyn amics and
tis sue phage distribution of the 1982 Smith and Huggin s study whi ch ca n be helpful in
ass ess ing the par ameter involved in successful phage therapy and its a ppare nt supe riority
to antibiotics . They have gone on to do very interesting animal studies o f their own and
co ncl ude that phage therapy is at least well worth further study.
In 1994 , So othill carried out a series of ve ry nice studi es prep ar atory to usin g
ph age s for infections of bum patients. Usin g gu inea pig s, he show ed that skin-g raft
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rejection could be prevented by prior treatment with phage against Pseudomonas

aerugino sa. He also saw excellent protection of mice against systemic infections with
both Pseudomonas and Acin etobacter when appropriate phages were used. In the latter
case, as few as 100 phages protected against infection with 100 million bacteria, 5 times
the LD501
Merrill and coworkers (1996) have carried out a series of experiments designed to
better understand the interactions of phages with the human immune system , and have
started a company called ''Exponential Biotherapies, Inc." to explore the possibilities of
phage therapy. Next year, for example , Exponential Biotherapies hopes to begin clinical
trials on a phage product that attacks a strain of enterococcus resistant to vancomycin, the
current antibiotic of last resort . Clinical trials aimed at developing a treatment against

Staphylococ cus aureus are presently being conducted . Evergreen State's biophysicist
Elizabeth Kutter estimates that phages might be used in American hospitals "when
nothing else works" within three to five years .

CHAPTER V
CO NCLUSION

It is said that the discovery and use or antibiotics and immunization procedure s
against infectiou s disease are two developm ent s in the fi eld of microbiology that have
co ntributed about twenty years to the average life span of humans in developed countries
where these practices are employed While the gr eater part of this span in time is
probably due to vaccination, most of us are either still alive or have family members who
are still alive because an antibiotic co nquered an infectiou s disease that otherwise would
have killed the individual lf we want to retain this medical luxury in our society we
must be vigilant and proactive we must fully underst and how and why anti-microbial
agents work , and why they don 't work, and realize that we must maintain a stride ahead
of microbial pathogens that can only be contained by oth er forms or therapy
It is clearly time to loo k more carefully at the potential of phage thera py, both
throu gh strongly suppo rting new research and examining carefully what is already
available. As Barrow and Soothill co nclude, " Phage therapy can be very effective in
certain conditions and has some unique advantages over antibiotics With the increasing
incidence of antibiotic resistant bacteria and a deficit in the development of new classes
of antibiotics to counteract them. there is a need to investigate the use of phage in a
range of infections" The stipulations of Ackermann (1987) are important here " Blind
treatmen t is clearly of no value, phages have to be tested Just as antibiotics. and the
indications have to be right, hut this holds everyw here

In

medicine. However. phage

thera py requires the creation of phage banks and a close collaboration between the
clinician and the labor atorv Phages defi nite!v have one major advantage Whil e the
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concentration of ant ibiot ics decreases from the moment of application, phage numbers
should increase. Another advantage is that phages are able to spread and thus prevent
disease . Nonetheless, much research remains to be done, on the stability of therapeutic
preparations; clearance of phages from blood and tissues; their multiplication in the
human body; inacti vation by ant ibodies, serum or pus ; and the release of bacterial
endotoxins by lysis. In addition, therapeutic phages should be characterized at least by
electron microscopy ." While it seems premature to generally introduce medicinal phage
preparations in the West without further extensive research, their carefully-implemented
use for a variety of agricultural purposes and in external applications could potentially
help reduce the emergence of antibiotic-resistant strains. Furthermore, compassionate
use of appropriate phages seems warranted in cases where bacteria resistant against all
available antibiot ics are ca using life-threatening illness . They are espec ially useful in
dealing with recalcitrant nosocomial infections, where large numbers of particularly
vulnerable people are being exposed to the same strains of bacteria in a closed hospital
setting In this case, the environment as well as the patients can be effe ctivel y treated
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